VEGFA and cancer: Shortly after, clinical trials with the anti-VEGF monoclonal antibody Bevacizumab as monotherapy or combination therapy were initiated, highlighting the benefit of anti-angiogenesis therapy as cancer treatment for many malignancies [14].